When Researchers Would Want a Non-Standard Ratio The 1:1 ratio is the right starting point for most BPC-157+TB-500 combination research, but specific research questions might call for different proportions: Studying angiogenesis-dominant repair models weight BPC-157 more heavily
The cascade of ROS formation causes oxidative damage to nucleic acid, lipoproteins, cell membranes, and native proteins
Approved by the FDA under the name Egrifta for HIV-related lipodystrophy, it has demonstrated an increase in IGF-1, a 15.2% reduction in visceral fat, and an improvement in body composition in Phase 3 trials
Nutr., 1992, doi: 10.1093/jn/122.5.1111
BPC-157 may enhance fibroblast activity, support collagen synthesis, influence angiogenesis, and upregulate skeletal muscle protein synthesis, making it effective for healing musculoskeletal injuries
The most comprehensive approach combines both, covering two of the three core biological pillars that drive cellular aging
